Development of an Inactivated Vaccine against SARS CoV-2

The rapid spread of SARS-CoV-2 with its mutating strains has posed a global threat to safety during this COVID-19 pandemic. Thus far, there are 123 candidate vaccines in human clinical trials and more than 190 candidates in preclinical development worldwide as per the WHO on 1 October 2021. The vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavel, Shaikh Terkis Islam, Yetiskin, Hazel, Uygut, Muhammet Ali, Aslan, Ahmet Furkan, Aydın, Günsu, İnan, Öznur, Kaplan, Büşra, Ozdarendeli, Aykut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624180/
https://www.ncbi.nlm.nih.gov/pubmed/34835197
http://dx.doi.org/10.3390/vaccines9111266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624180/
https://www.ncbi.nlm.nih.gov/pubmed/34835197
http://dx.doi.org/10.3390/vaccines9111266

Ejemplares similares